CN104825846A - 一种治疗面神经炎的中药组合物 - Google Patents
一种治疗面神经炎的中药组合物 Download PDFInfo
- Publication number
- CN104825846A CN104825846A CN201510180046.0A CN201510180046A CN104825846A CN 104825846 A CN104825846 A CN 104825846A CN 201510180046 A CN201510180046 A CN 201510180046A CN 104825846 A CN104825846 A CN 104825846A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- fructus
- medicine composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 208000014337 facial nerve disease Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims 5
- 238000001914 filtration Methods 0.000 claims 1
- -1 patch Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 241000305491 Gastrodia elata Species 0.000 abstract description 12
- 241000213006 Angelica dahurica Species 0.000 abstract description 11
- 240000000249 Morus alba Species 0.000 abstract description 11
- 235000008708 Morus alba Nutrition 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 11
- 241000951473 Schizonepeta Species 0.000 abstract description 8
- 230000036461 convulsion Effects 0.000 abstract description 5
- 206010010904 Convulsion Diseases 0.000 abstract description 4
- 241000037740 Coptis chinensis Species 0.000 abstract description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000405414 Rehmannia Species 0.000 abstract description 2
- 208000005392 Spasm Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000000295 complement effect Effects 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 241001166194 Geranium wilfordii Species 0.000 abstract 1
- 244000290970 Tetrapanax papyrifer Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 description 21
- 210000001508 eye Anatomy 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 241000208152 Geranium Species 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 10
- 241000219312 Chenopodium Species 0.000 description 9
- 241000405911 Rehmannia glutinosa Species 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 208000004929 Facial Paralysis Diseases 0.000 description 8
- 206010047700 Vomiting Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 230000008673 vomiting Effects 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 244000183685 Citrus aurantium Species 0.000 description 6
- 235000007716 Citrus aurantium Nutrition 0.000 description 6
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 6
- 235000016646 Citrus taiwanica Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 208000006373 Bell palsy Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 235000003385 Diospyros ebenum Nutrition 0.000 description 5
- 241000792913 Ebenaceae Species 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 210000001061 forehead Anatomy 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000008921 facial expression Effects 0.000 description 4
- 210000000256 facial nerve Anatomy 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010020559 Hyperacusis Diseases 0.000 description 3
- 235000011229 Prunus domestica subsp. syriaca Nutrition 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 244000169641 Spondias dulcis Species 0.000 description 3
- 235000005138 Spondias dulcis Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000010470 Ageusia Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 235000007877 Diospyros australis Nutrition 0.000 description 2
- 206010013642 Drooling Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010020989 Hypogeusia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010028347 Muscle twitching Diseases 0.000 description 2
- 241001529733 Nepeta Species 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 240000002577 Prunus nigra Species 0.000 description 2
- 235000010875 Prunus nigra Nutrition 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000008630 Sialorrhea Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241001125929 Trisopterus luscus Species 0.000 description 2
- 235000018288 Vitex doniana Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000001097 facial muscle Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 235000019570 hypogeusia Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- BFBPISPWJZMWJN-UHFFFAOYSA-N methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N=CCC(C)CCCC(C)(C)O BFBPISPWJZMWJN-UHFFFAOYSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 230000002618 waking effect Effects 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 235000007519 Chimonanthus praecox Nutrition 0.000 description 1
- 206010008796 Chromaturia Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000014526 Conduction disease Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000021401 Facial Nerve injury Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000249820 Lipotes vexillifer Species 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
- 206010061296 Motor dysfunction Diseases 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000001359 Origanum dictamnus Species 0.000 description 1
- 235000015987 Origanum dictamnus Nutrition 0.000 description 1
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000003770 Stephanotis floribunda Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 206010005159 blepharospasm Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004747 cranial fossa posterior Anatomy 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 201000002273 mucopolysaccharidosis II Diseases 0.000 description 1
- 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 238000010984 neurological examination Methods 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 208000011263 parotid disease Diseases 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 230000001007 puffing effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种治疗面神经炎的中药组合物,由以下重量份的原料制备而成:黄连8-12份,荆芥10-14份,白疾藜4-12份,天麻14-20份,羌活14-20份,老鹳草36-50份,枳壳10-14份,桑葚36-50份,熟地24-44份,黄梅花2-6份,白芷8-14份,乌梅1-4份,蒲黄6-10份,伏神15-19份,通草2-6份,豨莶草6-10份。本发明中,各药相辅相承,共起除湿化痰、祛风通络、理气活血、解痉、定惊搐,解毒的功能,选用天然中草药,用于治疗面神经炎见效快,具有疗效确切,无毒副作用,成本低,疗程短,治愈率高的特点。
Description
技术领域
本发明涉及一种中药组合物,具体地说涉及一种能够治疗面神经炎的中药组合物。
背景技术
面神经炎是神经系统疾病中的一种常见症状,面神经炎又称为面神经麻痹、贝尔氏麻痹,亨特综合症,俗称“面瘫”、“歪嘴巴”、“歪歪嘴”、“吊线风”,是以面部表情肌群运动功能障碍为主要特征的一种常见病,面神经炎与面神经损伤有关。面神经是人体内居于骨管中最长的神经,也是最容易受到损害的神经。 周围性面神经炎病因较为复杂,因为面神经很长,比较容易受累,其行走经络的任何病变都可导致面神经炎。其表现为口眼歪斜、言语不清、口角流言,中医称之为中风。现代医学认为该病是由于脑血管阻塞、面部血液循环不畅、患部神经传导失调所致。面部经络不畅就会导致人们面部神经麻痹,致使人们口齿不便、面部表情僵化,一般症状是口眼歪斜它是一种常见病、多发病,它不受年龄限制。患者面部往往连最基本的抬眉、闭眼、鼓嘴等动作都无法完成。不仅会影响自己与人交流,也会使其他人远离自己,造成严重的心理负担。目前的治疗方法中比较先进的是采用CTX—生物导融技术,但是费用比较高,由于病因复杂,且不明确,治疗的方法也不尽统一。
目前对于面神经炎的治疗多采用针灸、西药疗法,复发率很高、不能治愈,而且面部神经损伤严重,给病人带来极大的痛苦,需要改进,纯西药治疗效果不好,本发明提供了一种中药组合物,治疗效果好,费用低。 因导致面神经炎的病因不同,伴随人体症状各异,例如眼斜、口歪程度不同等。目前,临床上多采用口服抗病毒药或注射腺苷类营养神经物质的方式治疗面神经炎,虽然见效快,但药物的副作用明显,对人体有较大的影响,也有采用外用药治疗,但大多存在治疗效果不理想、疗程较长、成本较高、久治不愈、收效缓慢等问题。 由于引起面神经炎的病因不同,面神经炎按中医辨证有不同的证型,用药也各有差异。
发明内容
本发明的目的是提供一种治疗面神经炎的中药组合物,其疗效好无副作用。
本发明的技术方案如下:
一种治疗面神经炎的中药组合物,其特征在于,包括下列重量份的组分:黄连8-12份,荆芥10-14份,白疾藜4-12份,天麻14-20份,羌活14-20份,老鹳草36-50份,枳壳10-14份,桑葚36-50份,熟地24-44份,黄梅花2-6份,白芷8-14份,乌梅1-4份,蒲黄6-10份,伏神15-19份,通草2-6份,豨莶草6-10份。
上述治疗面神经炎的中药组合物中优选包括下列重量份的组分:黄连10-12份,荆芥12-14份,白疾藜6-12份,天麻16-18份,羌活16-18份,老鹳草38-46份,枳壳12-14份,桑葚38-46份,熟地28-40份,黄梅花3-5份,白芷10-12份,乌梅2-3份,蒲黄7-9份,伏神16-18份,通草3-5份,豨莶草7-9份。
上述治疗面神经炎的中药组合物中优选包括下列重量份的组分:黄连8份,荆芥10份,白疾藜4份,天麻14份,羌活14份,老鹳草36份,枳壳10份,桑葚36份,熟地24份,黄梅花2份,白芷8份,乌梅1份,蒲黄6份,伏神15份,通草2份,豨莶草6份。
上述治疗面神经炎的中药组合物中优选包括下列重量份的组分:黄连9份,荆芥11份,白疾藜6份,天麻16份,羌活16份,老鹳草38份,枳壳12份,桑葚38份,熟地28份,黄梅花3份,白芷10份,乌梅2份,蒲黄7份,伏神16份,通草3份,豨莶草7份。
上述治疗面神经炎的中药组合物中优选包括下列重量份的组分:黄连12份,荆芥14份,白疾藜12份,天麻18份,羌活18份,老鹳草46份,枳壳14份,桑葚46份,熟地40份,黄梅花5份,白芷12份,乌梅3份,蒲黄9份,伏神18份,通草5份,豨莶草9份。
本发明还提供了上述的一种治疗面神经炎的中药组合物的制备方法,包括下述步骤:
A、各中药成分按一定比例加水分别煎煮三次,每次各20分钟;
B、合并各药液,滤渣;
C、将滤液减压浓缩至相对为密度为1.2—1.35的稠膏,减压干燥。
D、在干燥后的稠膏中加入蔗糖粉,制粒,干燥。
本发明还提供了上述的一种治疗面神经炎的中药组合物的制剂,其特征在于,所述制剂为散剂、丸剂、片剂、胶囊剂、颗粒剂或口服液。
本发明还提供了上述的一种治疗面神经炎的中药组合物在制备治疗面神经炎产品中的应用。
本发明中各原料的药理药性如下:
黄连:性味归经:苦,寒,无毒。归心、脾、胃、肝、胆、大肠经。功能主治:清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。
荆芥:发表散风,透疹,属解表药下属分类的辛温解表药。
白疾藜:白疾藜--祛风明目,疏肝解郁。治:头目眩晕疼痛,肝 气郁结,目赤,多泪等。
天麻:为多年生草本植物,分布于全国大部分地区。其干燥块茎亦称天麻, 是一味常用而较名贵的中药,临床多用于头痛眩晕、肢体麻木、小儿惊风、癫 痫、抽搐、破伤风等症。
羌活:用于阳痿遗精,遗尿尿频,腰膝冷痛,肾虚作喘,五更泄泻;外用 治白癜风,斑秃;外感风寒、头痛无汗、油印寒湿痹、风水浮肿、疮疡肿毒。
老鹳草:性味归经:平;辛、苦;归肝、肾、脾经。功能主治:祛风湿,通经络,止泻痢。用于风湿痹痛,麻木拘挛,筋骨酸痛,泄泻痢疾。
枳壳:味苦、辛,性凉;归肺、脾、大肠经。具有破气行痰,消食化积之功效。
桑葚:甘、酸,滋阴补血、生津润燥、润肠排毒。
熟地:药性: 甘、微温 ,入肝、心、肾经。功能主治:滋阴,补血,滋肾养肝。主治阴虚血少,腰膝痿弱、劳嗽骨蒸,遗精,崩漏,月经不调,消渴,溲数,耳聋、目昏。
黄梅花:别称金梅、腊梅、蜡花、蜡梅花、蜡木、麻木紫、石凉茶、唐梅、香梅。性味归经:辛,温,无毒。归 肺、胃二经。功能主治:解暑生津,顺气止咳。用于暑热心烦、口渴、百日咳、肝胃气痛、水火烫伤。花蕾:解暑生津,开胃散郁,止咳。用于暑热头晕,呕吐,气郁胃闷,麻疹,百日咳;外用治烫火伤,中耳炎。根:祛风,解毒,止血。用于风寒感冒,腰肌劳损,风湿关节炎。根皮:外用治刀伤出血。
白芷:性温,味辛,归肺、脾、胃经,具有解表散寒,祛风止痛,通鼻窍,燥湿止带,消肿排脓的功效,主治头痛,眉棱骨痛,齿痛,鼻渊,寒湿腹痛,肠风痔漏,赤白带下,痈疽疮疡,皮肤燥痒,疥癣等证。
乌梅:性酸、涩,平。归肝、脾、肺、大肠经。功能主治:敛肺,涩肠,生津,安蛔。用于肺虚久咳;虚热烦渴;久疟;久泻;痢疾;便血;尿血;血崩;蛔厥腹痛;呕吐;钩虫病。
蒲黄:止血,祛瘀,利尿。
伏神:又名茯神。性味归经:甘淡,平。味甘淡,性微温。归入心、脾经。功用主治:宁心,安神,利水。治心虚惊悸,健忘,失眠,惊痫,小便不利。疗风眩,风虚,五劳,口干,善忘,开心益智,养精神。治心虚气短,健脾利温。
通草:别名寇脱、离南、活莌、倚商等,为五加科植物通脱木的茎髓。性味归经:甘;淡;微寒,入肺、胃经。功能主治:清湿利水;通乳。主淋症涩痛;小便不利;水肿;黄疸;湿温病;小便短赤;产后乳少;经闭;带下。用于湿温尿赤,淋病涩痛,水肿尿少,乳汁不下。除水肿癃闭,治五淋。
豨莶草:性味归经:苦,寒,有小毒,入肝、脾、肾经。功能主治:祛风湿,利筋骨,降血压。
本发明采用黄连、荆芥、白疾藜、天麻、羌活、老鹳草、枳壳、桑葚、熟地、黄梅花、白芷、乌梅、蒲黄、伏神、通草、豨莶草多种药材科学组合,各药相辅相承,共起除湿化痰、祛风通络、理气活血、解痉、定惊搐,解毒的功能,选用天然中草药,用于治疗面神经炎见效快,具有疗效确切,无毒副作用,成本低,疗程短,治愈率高的特点。
具体实施方式
下面结合实施例,更具体地说明本发明的内容。应当理解,本发明的实施并不局限于下面的实施例,对本发明所做的任何形式上的变通和/或改变都将落入本发明保护范围。
在本发明中,若非特指,所有的份、百分比均为重量单位,所有的设备和原料等均可从市场购得或是本行业常用的。下述实施例中的方法,如无特别说明,均为本领域的常规方法。
实施例1:一种治疗面神经炎的中药组合物,包括下列组分:黄连8g,荆芥10g,白疾藜4g,天麻14g,羌活14g,老鹳草36g,枳壳10g,桑葚36g,熟地24g,黄梅花2g,白芷8g,乌梅1g,蒲黄6g,伏神15g,通草2g,豨莶草6份。
实施例2:一种治疗面神经炎的中药组合物,包括下列组分:黄连9份,荆芥11g,白疾藜6g,天麻16g,羌活16g,老鹳草38g,枳壳12g,桑葚38g,熟地28g,黄梅花3g,白芷10g,乌梅2g,蒲黄7g,伏神16g,通草3g,豨莶草7g。
实施例3:一种治疗面神经炎的中药组合物,包括下列组分:黄连12g,荆芥14g,白疾藜12g,天麻18g,羌活18g,老鹳草46g,枳壳14g,桑葚46g,熟地40g,黄梅花5g,白芷12g,乌梅3g,蒲黄9g,伏神18g,通草5g,豨莶草9g。
其中实施例1-3的制备方法均包括以下步骤:
A、各中药成分按一定比例加水分别煎煮三次,每次各一个小时;
B、合并各药液,滤渣;
C、将滤液减压浓缩至相对为密度为1.0—1.15的稠膏,减压干燥。
D、在干燥后的稠膏中加入蔗糖粉,制粒,干燥。
毒性实验:
急性毒性实验:
应用NIH小鼠80只,SPF级,雌雄各半,体重18~22g,进行急性毒性试验。小鼠随机分为两组,每组40只,即对照组和给药组,实验前禁食12小时;将本发明的实施例3制备的制剂溶解在水中,(浓度为4.13g生药/ml,最高浓度)灌胃,灌胃容积为5ml/kg(即单次给药剂量为20.6生药/kg),对照组给予等量生理盐水,一天给药2次,给药间隔时间9小时,给药后连续观察21天,并记录小鼠的的毒性反应及死亡数。实验结果表明:与对照组比较,给药后小鼠未见明显差异,实验连续观察21天,小鼠全身状况、饮食、饮水、体重增长均正常。小鼠口服灌胃本发明的制剂LD50>20.6生药/kg,每日最大给药量为41.2生药/kg/日。本发明的中药临床用药量为1.9g生药/日/人,成人体重以60KG计,平均用药剂量为0.028g生药/kg/日。按体重计:小鼠(平均体重以20g计)口服灌胃本发明的中药制剂的耐受量为临床用量的723倍。因此本发明的中药制剂急性毒性低,临床用药安全。
本发明的治疗慢性面神经炎的中药组合物,临床疗效总结:
一、 样本选择
本发明经临床病例90例中,男50例,女40例,年龄30岁-45岁,病程最短者4天,最长者达42天。随机分成两组,治疗组46人,男性29人,女性17人;对照组44人,男性21人,女性23人。两组均每日治疗1次,5次为一疗程,疗程间休息2天,治疗4周。所有病例观察至接受治疗起4周止。其间若已治愈则停止治疗。
二、诊断标准
所有病例均符合《神经病学》中周围性面神经麻痹的诊断标准。临床表现为起病突然,每在睡眠醒来时发现单侧面部板滞、麻木、瘫痪、不能蹙眉、皱眉、露齿、鼓颊等动作,漱口漏水,眼睑闭合不全,迎风流泪,口角歪向健侧,额纹消失或变浅,眼裂增宽,鼓腮时单侧口角漏气。部分患者初起还有耳后、耳前及面部疼痛,或伴患侧舌前2/3味觉 减退或消失,听觉过敏。患侧面部表情肌瘫痪,额纹消失,鼻唇沟变浅,口角下垂,露齿时口角歪向健侧。并已排除其他疾病(包括吉兰-巴雷综合征、后颅窝肿瘤、神经莱姆病、糖尿病、创伤、腮腺疾病及中耳炎等)引发面瘫的可能,除周围性面瘫外,无其他神经系统阳性体征。排除标准中枢性面神经麻痹、后颅窝病变引起的面神经麻痹、周围性面神经麻痹超过 3 个月,伴有严重高血压及其他严重器质性疾病的患者。
三、治疗方法
临床应用时,组合物中的组分、用量根据患者的体重、年龄及症状酌情增减。治疗组:十天为一疗程,一天一剂,水煎三遍,分早、中、晚三次饭前半小时温热服用。服药期间忌食生冷、辛辣、刺激之物。
对照组:十天为一疗程,强的松片20mg每日一次口服,维生素B1片20mg每日三次口服,维生素B12注射液0.5mg隔日一次肌注。
所有患者治疗期间患者应该避风,避寒冷刺激,适当休息。
四、疗效标准
采用House-Braekmann(H-B)分级量表。痊愈:达H-B I级,双侧额纹、鼻唇沟恢复对称,闭眼正常,鼓腮时口角不漏气,示齿无歪斜,面部表情正常;症状与体征完全消失,口、眼及面部肌肉活动自如,神经系统检查功能恢复正常,显效:达H-B II级,即双侧额纹与鼻唇沟基本对称,眼闭合欠实,示齿时见口角略不对称,鼓腮时口角不漏气;症状与体征基本消失,口、眼及面部肌肉基本活动自如,神经系统检查功能基本恢复正常,好转:由H-B IV~VI级经治疗后改善为III级以上;无效:症状与体征无改善,神经系统检查功能无恢复,治疗后仍停留在H-BIV级以上。
五、治疗效果:该临床观察病例中,服药2个疗程
治疗组:痊愈42例(其中,第1疗程,痊愈30例,占痊愈人数的61.43%),显效2例,好转2例,无效0例。治愈率达到91.3%,总有效率达到100%。随访12个月,无复发。
对照组:痊愈25例(其中,第1疗程,痊愈8例,占痊愈人数的32%),显效4例,好转6例,无效9例。治愈率达到56.82%,总有效率达到76.09%。随访12个月,4例复发,占痊愈人数的16%。
六、具体病例
病例1:姜某,男,38岁,患者晨起后因漱口漏水,始发现口眼歪斜。遂来我院治疗。检查左侧额纹消失,蹙额、皱眉不能,左眼不能全闭,口角向右歪斜,鼓颊、吹哨、露齿动作不能完成。伴有神疲,气短乏力,食少,脉细,舌淡苔白。西医诊断:面神经麻痹(周围性)。中医诊断:面瘫(风寒证)。证属正气不足,感受风寒之邪,经络闭阻,筋脉失养。服用本发明实施例3的制剂,每日3次,每次200ml,15天后痊愈,随访1年未复发。
病例2:李某,女,29岁,生产后仍在哺乳中,发病前三天于后背刮痧,后觉睡前右侧面部神经抽动,眼皮跳动,嘴唇上挑,夜间睡觉右耳根疼痛,胀痛难忍难以入眠,晨起后自觉右侧面部肌肉活动缓慢、肌肉僵硬不受控,颈项、腰、后背酸痛,略有乏累、心情低落,便调。脉弦,舌边尖红苔薄白。患者表现为情志不舒,心烦意乱,患者每晚入睡困难,时睡时醒,致全身乏力疲劳。服用本发明中药,1疗程症状减轻,共用3疗程,症状消除。随访,未复发。
病例3:胡某某,女,47岁,因工作压力大,1月前出现面瘫,有局部受风寒侵袭史,突然口角流涎、斜,味觉减退,听觉过敏,眼睑闭合不全,病侧鼻唇沟平坦变浅,口角下垂,歪向健侧,口涎外流,不能完成鼓腮、撅嘴、吹哨等动作,有时病侧面肌发生不自主的抽动,服用本发明药物一个疗程后,患者自我感觉症状明显缓解,口角流涎、斜,味觉减退,听觉过敏,眼睑闭合不全明显减少,口角流涎、斜消失,继续服用本发明药物一个疗程后,能完成鼓腮、撅嘴、吹哨等动作,继续一疗程巩固疗效。后经服用本发明药物2疗程症状减轻,共用4疗程,症状消除。随访,未复发。
Claims (8)
1.一种治疗面神经炎的中药组合物,其特征在于,包括下列重量份的组分:黄连8-12份,荆芥10-14份,白疾藜4-12份,天麻14-20份,羌活14-20份,老鹳草36-50份,枳壳10-14份,桑葚36-50份,熟地24-44份,黄梅花2-6份,白芷8-14份,乌梅1-4份,蒲黄6-10份,伏神15-19份,通草2-6份,豨莶草6-10份。
2.根据权利要求1所述的一种治疗面神经炎的中药组合物,其特征在于,包括下列重量份的组分:黄连10-12份,荆芥12-14份,白疾藜6-12份,天麻16-18份,羌活16-18份,老鹳草38-46份,枳壳12-14份,桑葚38-46份,熟地28-40份,黄梅花3-5份,白芷10-12份,乌梅2-3份,蒲黄7-9份,伏神16-18份,通草3-5份,豨莶草7-9份。
3.根据权利要求1所述的一种治疗面神经炎的中药组合物,其特征在于,包括下列重量份的组分:黄连8份,荆芥10份,白疾藜4份,天麻14份,羌活14份,老鹳草36份,枳壳10份,桑葚36份,熟地24份,黄梅花2份,白芷8份,乌梅1份,蒲黄6份,伏神15份,通草2份,豨莶草6份。
4.根据权利要求1所述的一种治疗面神经炎的中药组合物,其特征在于,包括下列重量份的组分:黄连9份,荆芥11份,白疾藜6份,天麻16份,羌活16份,老鹳草38份,枳壳12份,桑葚38份,熟地28份,黄梅花3份,白芷10份,乌梅2份,蒲黄7份,伏神16份,通草3份,豨莶草7份。
5.根据权利要求1所述的一种治疗面神经炎的中药组合物,其特征在于,包括下列重量份的组分:黄连12份,荆芥14份,白疾藜12份,天麻18份,羌活18份,老鹳草46份,枳壳14份,桑葚46份,熟地40份,黄梅花5份,白芷12份,乌梅3份,蒲黄9份,伏神18份,通草5份,豨莶草9份。
6.一种制备权利要求1所述中药组合物的方法,其特征在于,包括以下步骤:
A、各中药成分按原料:水的重量比1:30-50加水分别煎煮三次,每次各20分钟;
B、合并各药液,滤渣;
C、将滤液减压浓缩至相对为密度为1.2—1.35的稠膏,减压干燥,
D、在干燥后的稠膏中加入蔗糖粉,制粒,干燥。
7.一种含有如权利要求1所述中药组合物的制剂,其特征在于,所述制剂为散剂、丸剂、片剂、胶囊剂、贴剂、颗粒剂或口服液。
8.一种如权利要求1所述中药组合物在制备治疗面神经炎产品中的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510180046.0A CN104825846A (zh) | 2015-04-16 | 2015-04-16 | 一种治疗面神经炎的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510180046.0A CN104825846A (zh) | 2015-04-16 | 2015-04-16 | 一种治疗面神经炎的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104825846A true CN104825846A (zh) | 2015-08-12 |
Family
ID=53804290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510180046.0A Pending CN104825846A (zh) | 2015-04-16 | 2015-04-16 | 一种治疗面神经炎的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104825846A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106039006A (zh) * | 2016-06-29 | 2016-10-26 | 杨晨阳 | 一种治疗面神经炎的中药组合物及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169940A (zh) * | 2013-04-16 | 2013-06-26 | 薛洪喜 | 一种治疗面瘫的药物 |
| CN103263658A (zh) * | 2013-05-30 | 2013-08-28 | 孙振芳 | 一种治疗周围性面瘫的中药制剂及其制备方法 |
-
2015
- 2015-04-16 CN CN201510180046.0A patent/CN104825846A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169940A (zh) * | 2013-04-16 | 2013-06-26 | 薛洪喜 | 一种治疗面瘫的药物 |
| CN103263658A (zh) * | 2013-05-30 | 2013-08-28 | 孙振芳 | 一种治疗周围性面瘫的中药制剂及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 郑青松等: ""面瘫120例疗效观察"", 《中国自然医学杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106039006A (zh) * | 2016-06-29 | 2016-10-26 | 杨晨阳 | 一种治疗面神经炎的中药组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN103860941A (zh) | 一种治疗精神分裂症的中药及其制备方法 | |
| CN104491695A (zh) | 一种治疗黄褐斑的药物组合物 | |
| CN104383257A (zh) | 一种治疗肝郁阴虚型干眼症的中药制剂 | |
| CN102727648A (zh) | 一种治疗白癜风的中药组合物 | |
| CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
| CN103751591A (zh) | 一种治疗阴阳两虚型高脂血症的中药制备方法 | |
| CN103142897B (zh) | 一种贲门失弛缓症术后用药 | |
| CN103751679A (zh) | 一种治疗肝肾阴虚型高脂血症的中药制备方法 | |
| CN104825846A (zh) | 一种治疗面神经炎的中药组合物 | |
| CN107823293A (zh) | 治疗口腔溃疡的瑶医外用散剂及其制备方法 | |
| CN106421335A (zh) | 一种治疗慢性咽炎的复方药物 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN116139236B (zh) | 一种治疗肝郁型失眠症的中药组合物及其应用 | |
| CN104524479A (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
| CN103142898B (zh) | 一种贲门失弛缓症术后用药的制备方法 | |
| CN109172686A (zh) | 治疗老年性皮肤瘙痒症的中药组合物及其制备方法和应用 | |
| CN102441103A (zh) | 一种治疗失眠症的药物 | |
| CN107595998B (zh) | 一种用于中风恢复期的中药组合物及其制备方法 | |
| CN103191335B (zh) | 一种治疗食道失弛缓症的药物组合物 | |
| CN103191338B (zh) | 一种治疗小儿贲门失弛缓症的药物组合物 | |
| CN102671149B (zh) | 治疗痢疾鸦胆子中药口服液及制备方法 | |
| CN115364185A (zh) | 一种通降胃气治疗胃胀的中药片剂 | |
| CN119386123A (zh) | 一种用于治疗过敏性鼻炎的口服组合物 | |
| CN116459322A (zh) | 一种治疗特应性皮炎的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150812 |
|
| RJ01 | Rejection of invention patent application after publication |